Deferasirox Patent Expiration

Deferasirox is used for treating allergies and allergic reactions. It was first introduced by Novartis Pharmaceuticals Corp in its drug Exjade on Nov 2, 2005. Other drugs containing Deferasirox are Jadenu, Jadenu Sprinkle. 20 different companies have introduced drugs containing Deferasirox.


Deferasirox Patents

Given below is the list of patents protecting Deferasirox, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Exjade US6465504 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Apr 05, 2019

(Expired)

Novartis
Exjade US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Jun 24, 2017

(Expired)

Novartis
Jadenu US6465504 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Apr 05, 2019

(Expired)

Novartis Pharms Corp
Jadenu US6596750 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Jun 24, 2017

(Expired)

Novartis Pharms Corp
Jadenu US9283209 Oral formulations of deferasirox Nov 21, 2034 Novartis Pharms Corp
Jadenu Sprinkle US6465504 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators Apr 05, 2019

(Expired)

Novartis


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Deferasirox Generics

Several generic applications have been filed for Deferasirox. The first generic version for Deferasirox was by Actavis Elizabeth Llc and was approved on Jan 26, 2016. And the latest generic version is by Mylan Pharmaceuticals Inc and was approved on May 17, 2024.

Given below is the list of companies who have filed for Deferasirox generic.


1. BIONPHARMA

Bionpharma Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Bionpharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG tablet, for suspension Prescription ORAL AB Nov 20, 2019


2. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG tablet, for suspension Prescription ORAL AB Jan 26, 2016
125MG tablet, for suspension Prescription ORAL AB Jan 26, 2016
500MG tablet, for suspension Prescription ORAL AB Jan 26, 2016
360MG tablet Prescription ORAL AB Dec 13, 2019
90MG tablet Prescription ORAL AB Dec 13, 2019
180MG tablet Prescription ORAL AB Dec 13, 2019


3. PIRAMAL HLTHCARE UK

Piramal Healthcare Uk Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Piramal Hlthcare Uk.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG tablet Prescription ORAL AB Dec 30, 2019
360MG tablet Prescription ORAL AB Dec 30, 2019
180MG tablet Prescription ORAL AB Jun 15, 2020


4. CIPLA

Cipla Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG granule Prescription ORAL AB Feb 23, 2022
360MG granule Prescription ORAL AB Feb 23, 2022
180MG granule Prescription ORAL AB Feb 23, 2022


5. ANNORA PHARMA

Annora Pharma Private Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Annora Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG granule Prescription ORAL AB Sep 22, 2022
90MG granule Prescription ORAL AB Mar 16, 2023
180MG granule Prescription ORAL AB Sep 22, 2022


6. AMNEAL

Amneal Eu Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
180MG granule Discontinued ORAL N/A Feb 9, 2021
360MG granule Discontinued ORAL N/A Feb 9, 2021
90MG granule Discontinued ORAL N/A Aug 2, 2021


7. MYLAN

Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
180MG granule Prescription ORAL AB May 3, 2024
360MG granule Prescription ORAL AB May 3, 2024
90MG granule Prescription ORAL AB May 3, 2024
250MG tablet, for suspension Prescription ORAL AB May 17, 2024
125MG tablet, for suspension Prescription ORAL AB May 17, 2024
500MG tablet, for suspension Prescription ORAL AB May 17, 2024


8. AUCTA

Aucta Pharmaceuticals Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Aucta.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG granule Prescription ORAL AB Mar 9, 2021
360MG granule Prescription ORAL AB Mar 9, 2021
180MG granule Prescription ORAL AB Mar 9, 2021


9. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
125MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
500MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
90MG tablet Prescription ORAL AB Jan 2, 2020
360MG tablet Prescription ORAL AB Jan 2, 2020
180MG tablet Prescription ORAL AB Jun 15, 2020


10. GLENMARK SPECLT

Glenmark Specialty Sa has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG tablet, for suspension Prescription ORAL AB Jan 6, 2020
250MG tablet, for suspension Prescription ORAL AB Jan 6, 2020
125MG tablet, for suspension Prescription ORAL AB Jan 6, 2020


11. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
360MG tablet Prescription ORAL AB Nov 20, 2019
90MG tablet Prescription ORAL AB Nov 20, 2019
180MG tablet Prescription ORAL AB Jun 15, 2020


12. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
360MG granule Prescription ORAL AB Jul 14, 2020
90MG granule Prescription ORAL AB Jul 14, 2020
180MG granule Prescription ORAL AB Jul 14, 2020


13. STEVENS J

Jerome Stevens Pharmaceuticals Inc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Stevens J.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG tablet Discontinued ORAL N/A Dec 27, 2019
360MG tablet Discontinued ORAL N/A Dec 27, 2019
180MG tablet Discontinued ORAL N/A Jun 15, 2020


14. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
180MG tablet Prescription ORAL AB Oct 16, 2023
90MG tablet Prescription ORAL AB Oct 16, 2023
360MG tablet Prescription ORAL AB Oct 16, 2023


15. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG granule Prescription ORAL AB Nov 19, 2021
90MG granule Prescription ORAL AB Nov 19, 2021
180MG granule Prescription ORAL AB Nov 19, 2021
250MG tablet, for suspension Discontinued ORAL N/A Sep 23, 2022
500MG tablet, for suspension Discontinued ORAL N/A Sep 23, 2022
125MG tablet, for suspension Discontinued ORAL N/A Sep 23, 2022


16. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 3 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG tablet Prescription ORAL AB May 27, 2021
180MG tablet Prescription ORAL AB May 27, 2021
90MG tablet Prescription ORAL AB May 27, 2021


17. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
360MG tablet Prescription ORAL AB Nov 20, 2019
90MG tablet Prescription ORAL AB Nov 20, 2019
500MG tablet, for suspension Discontinued ORAL N/A May 5, 2020
125MG tablet, for suspension Discontinued ORAL N/A May 5, 2020
250MG tablet, for suspension Discontinued ORAL N/A May 5, 2020
180MG tablet Prescription ORAL AB Jun 15, 2020


18. MSN

Msn Laboratories Private Ltd has filed for 6 different strengths of generic version for Deferasirox. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
90MG granule Prescription ORAL AB Apr 20, 2022
500MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
125MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
250MG tablet, for suspension Prescription ORAL AB Nov 20, 2019
360MG granule Prescription ORAL AB Mar 17, 2021
180MG granule Prescription ORAL AB Mar 17, 2021